Nomura Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Buy
462,909
+106,023
+30% +$5.02M 0.05% 290
2025
Q4
$18.2M Sell
356,886
-617,984
-63% -$31.6M 0.02% 342
2025
Q3
$54.1M Buy
974,870
+607,044
+165% +$35.5M 0.08% 149
2025
Q2
$25.4M Buy
367,826
+164,975
+81% +$11.2M 0.05% 209
2025
Q1
$14.1M Buy
202,851
+50,057
+33% +$4.13M 0.03% 377
2024
Q4
$13.1M Buy
152,794
+137,856
+923% +$14.9M 0.02% 429
2024
Q3
$1.78M Buy
14,938
+11,471
+331% +$1.53M ﹤0.01% 976
2024
Q2
$495K Buy
3,467
+1,331
+62% +$176K ﹤0.01% 1326
2024
Q1
$274K Sell
2,136
-6,746
-76% -$803K ﹤0.01% 1383
2023
Q4
$919K Buy
8,882
+3,072
+53% +$304K ﹤0.01% 1201
2023
Q3
$528K Buy
+5,810
New +$512K ﹤0.01% 1117
2020
Q1
Sell
-36,860
Closed -$1.07M 1140
2019
Q4
$1.07M Buy
+36,860
New +$1.02M ﹤0.01% 782
2014
Q4
Sell
-65,752
Closed -$1.39M 2580
2014
Q3
$1.39M Buy
65,752
+3,042
+5% +$70K ﹤0.01% 1285
2014
Q2
$1.44M Sell
62,710
-1,016
-2% -$22.4K ﹤0.01% 1293
2014
Q1
$1.45M Buy
63,726
+15,896
+33% +$339K ﹤0.01% 1319
2013
Q4
$880K Buy
47,830
+28,530
+148% +$497K ﹤0.01% 1039
2013
Q3
$327K Sell
19,300
-53,250
-73% -$896K ﹤0.01% 1633
2013
Q2
$1.13M Buy
+72,550
New +$1.21M 0.01% 932

Other funds holding NVO

Nomura Holdings's NVO Position: Q1 2026 in Review

Nomura Holdings increased its Novo Nordisk (NVO) stake by 30% in Q1 2026, buying an estimated $5.02M and bringing the position to 462,909 shares worth $17M. The position accounts for 0.05% of the portfolio, ranked #290.

Nomura Holdings first reported a position in NVO in Q2 2013 and has held it in 18 quarters since. The position peaked at $54.1M in Q3 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Nomura Holdings held 462,909 shares of Novo Nordisk worth $17M as of Q1 2026.
  • Nomura Holdings bought 106,023 Novo Nordisk shares in Q1 2026, an estimated $5.02M.
  • Novo Nordisk made up 0.05% of Nomura Holdings's portfolio in Q1 2026, its #290 holding.
  • Nomura Holdings first reported a position in Novo Nordisk in Q2 2013 and has held it in 18 quarters since.
  • Nomura Holdings's Novo Nordisk position peaked at $54.1M in Q3 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.